Announcement //

UChicago, Duality Teams to Pitch at 2021 Chicago Venture Summit

Several teams from the University of Chicago and Duality – the world’s first accelerator focused exclusively on quantum technologies – are pitching at the 2021 Chicago Venture Summit. The…
News //

UChicago Spin-Out AccuraDX Launches KAS-seq Research Kits: ‘A New Way to Study Important Biological Processes and Regulatory Pathways’

A University of Chicago spin-out company AccuraDX this week has launched its KAS-Direct™ single-stranded DNA (ssDNA) Labeling and Enrichment Kit. Founded in 2020, the company, which is headquartered in Natick,…
News //

NanoPattern Receives $1 Million NSF Grant: ‘A Validation of Our Vision,’ Says Cofounder

NanoPattern Technologies recently received a $999,428 grant from the National Science Foundation’s (NSF) Phase II Small Business Innovation Research (SBIR) grant program. Cofounded by Dmitri Talapin, Ernest DeWitt Burton Distinguished…
News //

UChicago Spin-Out Gives Researchers a Genome-Wide View of Cell Transcription

A University of Chicago spin-out company, AccuraDX is developing next-generation sequencing (NGS) technologies that enable researchers to map the location of single-stranded DNA (ssDNA) on the genome. The innovation came…
Announcement //

Researchers to Know: UChicago Professors Kunle Odunsi and Rama Ranganathan Recognized for Groundbreaking Work

The Illinois Science and Technology Coalition (ISTC) this year has named University of Chicago Professors Kunle Odunsi and Rama Ranganathan as among its 2021 Researchers to Know. "Research activity at…
News //

Multifunctional Nanomedicine Developed Using Novel UChicago Tech Gets FDA Nod to Initiate Clinical Trials

Coordination Pharmaceuticals, Inc. (CPI) recently announced that the FDA has approved the company's Investigational New Drug (IND) application to initiate a first-in-human Phase 1 clinical study of its novel cancer…
News //

Special Report >> Immunoengineering Deep Dive: What It Is and Why It Matters to the Future of Fighting Disease

In this special report, presented in part with the Immunoengineering 2021 conference and Takeda Pharmaceuticals, the Polsky Center for Entrepreneurship and Innovation explores work from across the University of…
News //

UChicago Grants InFlectis BioScience Exclusive Rights to a Potential New Class of Therapies for Neuromuscular Diseases

The University of Chicago’s Polsky Center for Entrepreneurship and Innovation has granted InFlectis BioScience rights to use a patented family of small molecules for the treatment of neuromuscular diseases. Per…
News //

Cancer’s Achilles’ Heel? UChicago Startup Secures $7 Million to Develop ‘Game-Changer’ Treatments

Onchilles Pharma recently closed its Series A funding round, bringing in approximately $7 million, including a $500,000 investment from the University of Chicago’s Startup Investment Fund. Cofounded by UChicago Associate…
News //

Novel Wound Dressing Seals, Protects, and Prevents Scar Formation with ‘Significant’ Advantages

University of Chicago researcher Xiaoyang Wu has developed a novel wound dressing that can stop bleeding while preventing infection and scarring using a single material, which has potential applications in…

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

Accept